Please login to the form below

Not currently logged in
Email:
Password:

business strategy

This page shows the latest business strategy news and features for those working in and with pharma, biotech and healthcare.

British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura

British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura

According to The Times, Britain’s secretary of state for business, energy and industrial strategy Kwasi Kwarteng has asked officials to monitor the deal to ‘better understand’ PMI’s plans for ... its ‘Beyond Nicotine’ strategy.

Latest news

More from news
Approximately 12 fully matching, plus 135 partially matching documents found.

Latest Intelligence

  • The pursuit of patient diversity in clinical trials The pursuit of patient diversity in clinical trials

    Patient-centricity was a conversation about good intentions rather than business critical,” said Mark Evans. ... That’s a business strategy challenge and it needs to be considered from the get-go – when companies are deciding where they want to play

  • Strategy experts: the real thing Strategy experts: the real thing

    What defines genuine strategy experts in the biomedical industry? The biomedical business applies massive means to meet essential ends. ... In the biomedical business, ‘publication strategy’ and ‘meetings strategy’, for example, fail to meet

  • Integrating competitive intelligence into business development, licensing and M&A strategy Integrating competitive intelligence into business development, licensing and M&A strategy

    One of the most profitable areas for biopharma companies to see the greatest return on their competitive intelligence (CI)  investment is through its application to business development and licensing (BD&L) ... Alfred Reszka is Chief Business Officer of

  • Is creativity in quarantine? Is creativity in quarantine?

    However, in recent years, models to help quantify the links between creativity and business performance have advanced. ... This never goes away. However, we are seeing more and more functions across client organisations, access, medical, business strategy

  • The science of the deal The science of the deal

    It is estimated that more than 75% of business development deals fall into this asymmetric R&D category. ... Professor Brian D Smith(brian.smith@pragmedic.com) is an author, academic and advisor specialising in the evolution of business models and

More from intelligence
Approximately 3 fully matching, plus 36 partially matching documents found.

Latest appointments

  • AZ appoints Alexion’s Aradhana Sarin as chief financial officer AZ appoints Alexion’s Aradhana Sarin as chief financial officer

    Currently, Sarin serves as executive vice president and chief financial officer of Alexion, a role she progressed to after joining the company in 2017 as chief business and strategy officer. ... Dunoyer will then go on to become chief executive officer

  • AstraZeneca taps internal candidate to become UK president AstraZeneca taps internal candidate to become UK president

    He has also worked as president of AZ’s Korea business, and also as AZ’s strategy and business development director of the Asia Pacific region. ... Prior to joining AZ, Keith-Roach worked in technology venture capital and strategy consulting for a

  • Bedrock Group bolsters team with three key appointments Bedrock Group bolsters team with three key appointments

    Pharmacology, and began his career in medical education in 2009. In addition to his new role at Bedrock, he works as principal advisor, scientific and business strategy at MYELOMA360. ... Prior to these roles, Jobson (pictured right) served as director

  • Lucid Group names Neil Flash chief commercial officer Lucid Group names Neil Flash chief commercial officer

    His balance of commercial strategy, business and people focus make him a perfect fit for Lucid as he leads a core part of our business,” said Dennis O’Brien, Lucid Group

  • New hires at Abbott, Kite and Arrakis Therapeutics New hires at Abbott, Kite and Arrakis Therapeutics

    Jude Medical – Abbott’s largest acquisition. He also led Abbott’s Diabetes Care business and the launch of the FreeStyle Libre. ... The breadth of her expertise and her track record of creating value through focused drug development and creative

More from appointments
Approximately 0 fully matching, plus 73 partially matching documents found.

Latest from PMHub

  • Attracting the best talent to build Lucid’s future

    I enjoy working with the key stakeholders of a business to create a recruitment strategy that enables us to find future stars of the organisation. ... The business has gone through multiple acquisitions over the last 2 years, backed by private equity

  • Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role

    and global businesses. Together, this approach will ensure that Fishawack Health balances the wellbeing, diversity, and development of our employees while growing the business in a fast-changing dynamic marketplace. ... She also spent a significant part

  • YV Intelligence

    YV Intelligence is the top market research and business strategy consulting firm that offers in-depth market research reports and consulting services.

  • MnB Intelligence

    MnB Intelligence is a strategy consulting firm providing actionable business intelligence to organizations worldwide. ... We provide a 360 framework for a range of business-oriented solutions, including competitive positioning, data framework, market

  • Redbow Consulting Group Redbow Consulting Group

    Who we are. redbow consulting group is a specialist healthcare strategy consulting company founded in 2013 by  Jonathan Dancer. ... Organisational Strategy &Health. Direction Setting &Leadership. Enabling the Organisation. Strategy Development.

More from PMHub
Approximately 7 fully matching, plus 40 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...